Researchers substantiated the effectiveness of CAR-T cells targeting PSCA, FRα, PD-L1, c-MET, CD133, CDH17, ICAM-1, and urokinase plasminogen activator surface receptor (uPAR) in GC models in the last 2 years [255, 269–275]. This evidence concerns the gene PLAUR and gastric cancer.